Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation
dc.contributor.author | Hoffman, S. A. | en_US |
dc.contributor.author | Wang, L. | en_US |
dc.contributor.author | Shah, Chirag V. | en_US |
dc.contributor.author | Ahya, V. N. | en_US |
dc.contributor.author | Pochettino, A. | en_US |
dc.contributor.author | Olthoff, Kim M. | en_US |
dc.contributor.author | Shaked, Abraham | en_US |
dc.contributor.author | Wille, K. | en_US |
dc.contributor.author | Lama, V. N. | en_US |
dc.contributor.author | Milstone, A. | en_US |
dc.contributor.author | Ware, L. B. | en_US |
dc.contributor.author | Orens, J. | en_US |
dc.contributor.author | Weinacker, A. | en_US |
dc.contributor.author | Demissie, E. | en_US |
dc.contributor.author | Bellamy, Scarlett | en_US |
dc.contributor.author | Kawut, S. M. | en_US |
dc.contributor.author | Hancock, W. W. | en_US |
dc.contributor.author | Christie, Jason D. | en_US |
dc.date.accessioned | 2010-06-01T19:01:08Z | |
dc.date.available | 2010-06-01T19:01:08Z | |
dc.date.issued | 2009-02 | en_US |
dc.identifier.citation | Hoffman, S. A.; Wang, L.; Shah, C. V.; Ahya, V. N.; Pochettino, A.; Olthoff, K.; Shaked, A.; Wille, K.; Lama, V. N.; Milstone, A.; Ware, L. B.; Orens, J.; Weinacker, A.; Demissie, E.; Bellamy, S.; Kawut, S. M.; Hancock, W. W.; Christie, J. D. (2009). "Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation." American Journal of Transplantation 9(2): 389-396. <http://hdl.handle.net/2027.42/72208> | en_US |
dc.identifier.issn | 1600-6135 | en_US |
dc.identifier.issn | 1600-6143 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72208 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19120076&dopt=citation | en_US |
dc.format.extent | 223225 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.rights | © 2009 American Society of Transplantation and the American Society of Transplant Surgeons | en_US |
dc.subject.other | Chemokines | en_US |
dc.subject.other | Cytokines | en_US |
dc.subject.other | Lung Transplantation | en_US |
dc.subject.other | Primary Graft Dysfunction | en_US |
dc.subject.other | Reperfusion Injury | en_US |
dc.title | Plasma Cytokines and Chemokines in Primary Graft Dysfunction Post-Lung Transplantation | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Pulmonary, Allergy, and Critical Care Medicine, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA | en_US |
dc.contributor.affiliationother | Division of Transplantation Immunology, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA | en_US |
dc.contributor.affiliationother | Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA | en_US |
dc.contributor.affiliationother | Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA | en_US |
dc.contributor.affiliationother | Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL | en_US |
dc.contributor.affiliationother | Division of Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, TN | en_US |
dc.contributor.affiliationother | Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University Hospital, Baltimore, MD | en_US |
dc.contributor.affiliationother | Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA | en_US |
dc.contributor.affiliationother | Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY | en_US |
dc.contributor.affiliationother | Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY | en_US |
dc.identifier.pmid | 19120076 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72208/1/j.1600-6143.2008.02497.x.pdf | |
dc.identifier.doi | 10.1111/j.1600-6143.2008.02497.x | en_US |
dc.identifier.source | American Journal of Transplantation | en_US |
dc.identifier.citedreference | Christie JD, Bavaria JE, Palevsky HI et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51 – 60. | en_US |
dc.identifier.citedreference | King RC, Binns OA, Rodriguez F et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000; 69: 1681 – 1685. | en_US |
dc.identifier.citedreference | Christie JD, Kotloff RM, Pochettino A et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232 – 1241. | en_US |
dc.identifier.citedreference | Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999; 340: 1081 – 1091. | en_US |
dc.identifier.citedreference | De Perrot M, Sekine Y, Fischer S et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002; 165: 211 – 215. | en_US |
dc.identifier.citedreference | Christie JD, Sager JS, Kimmel SE et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005; 127: 161 – 165. | en_US |
dc.identifier.citedreference | Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: Predictors and outcomes. J Heart Lung Transplant 2005; 24: 1483 – 1488. | en_US |
dc.identifier.citedreference | Christie JD, Kotloff RM, Ahya VN et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312 – 1316. | en_US |
dc.identifier.citedreference | Christie JD, Van Raemdonck D, de Perrot M et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: Introduction and methods. J Heart Lung Transplant 2005; 24: 1451 – 1453. | en_US |
dc.identifier.citedreference | Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454 – 1459. | en_US |
dc.identifier.citedreference | de Perrot M, Bonser RS, Dark J et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: Donor-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1460 – 1467. | en_US |
dc.identifier.citedreference | de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490 – 511. | en_US |
dc.identifier.citedreference | Barr ML, Kawut SM, Whelan TP et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: Recipient-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1468 – 1482. | en_US |
dc.identifier.citedreference | Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 1994; 58: 1158 – 1162. | en_US |
dc.identifier.citedreference | Naidu BV, Farivar AS, Woolley SM, Grainger D, Verrier ED, Mulligan MS. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant 2004; 23: 128 – 134. | en_US |
dc.identifier.citedreference | Wacholder S. Design issues in case control studies. Stat Methods Med Res 1995; 4: 293 – 309. | en_US |
dc.identifier.citedreference | Christie JD, Robinson N, Ware LB et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007; 175: 69 – 74. | en_US |
dc.identifier.citedreference | Covarrubias M, Ware LB, Kawut SM et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007; 7: 2573 – 2578. | en_US |
dc.identifier.citedreference | Frangogiannis NG. The role of the chemokines in myocardial ischemia and reperfusion. Curr Vasc Pharmacol 2004; 2: 163 – 174. | en_US |
dc.identifier.citedreference | Tatapudi RR, Muthukumar T, Dadhania D et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004; 65: 2390 – 2397. | en_US |
dc.identifier.citedreference | Melter M, Exeni A, Reinders ME et al. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001; 104: 2558 – 2564. | en_US |
dc.identifier.citedreference | Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001; 193: 975 – 980. | en_US |
dc.identifier.citedreference | Hancock WW, Lu B, Gao W et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000; 192: 1515 – 1520. | en_US |
dc.identifier.citedreference | Mathur A, Baz M, Staples ED et al. Cytokine profile after lung transplantation: Correlation with allograft injury. Ann Thorac Surg 2006; 81: 1844 – 1849; discussion 1849–1850. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.